Skip to main content icon/video/no-internet

Medicalization of the dying is a form of medical treatment that concentrates on reducing the patient's pain and suffering. It does not delay or speed up the progression of death. However, high-quality, endof-life care is limited, and most of the extant literature focuses on patients with cancer, thereby limiting the prospects for addressing the many important aspects of end-of-life care. This is noted in that hospice organizations serve most Americans dying of cancer and only 10#x0025; of all others.

History

Medicalization of the dying patient is a part of palliative care or hospice care. The concept of hospice is both a philosophy and a specialization that has important historical characteristics that are traceable to the Middle Ages, when in its embryonic form, life-rendering assistance was provided to those who engaged in the pilgrimage to the Holy Land. In the latter portion of the 19th century, a religious order of nuns established a hospice hospital for the dying in Dublin, Ireland, and then later in London, England.

The modern hospice movement originated in the United Kingdom after the founding of St. Christopher's Hospice in 1967 by Dame Ciceley Saunders. Training as a nurse and social worker sensitized Dame Saunders to what she observed and referred to as the patients' total suffering. The intensity of her observations of dying patients and the desire to assist them prompted her to pursue studies that ultimately led to a medical degree, after which she aggressively worked on behalf of pain-suffering patients on the verge of dying.

Hospice care in the United States, which began as volunteer-led movement, has evolved into a significant part of the health care system. From the initial hospital-based palliative care programs that began in the late 1980s, more than 1.2 million individuals and their families received hospice care during 2005. Much hospice care is delivered at the patients' home, but hospice care is also available in home-like hospice residences, nursing homes, assisted living facilities, veterans' facilities, hospitals, as well as prisons.

Symptoms

Patients with serious illness at the end of life should be regularly evaluated by clinicians for pain, breathlessness, anxiety, and depression. Each one of these symptoms can be treated with separate medications, as per palliative care protocols. Following is a short overview of the medications used to treat intractable breathlessness, anxiety, and fear.

Pain

Patients at the end of life are generally receiving treatments effective in managing pain. For patients with cancer, such therapies include nonsteroidal antiinflammatory drugs, opioids, and bisphosphonates. The available evidence is that the prevalence of pain is high in more than 50#x0025; in all cancer types, with the highest prevalence in head and neck cancer patients at 70#x0025;. More than one-third of the patients with pain grade their pain as moderate or severe. The World Health Organization (WHO) introduced a pain scale in 1986 that has been widely accepted. Combined with information pertaining to appropriate dosage guidelines, the scale offers sufficient evidence for clinicians to adequately access and implement adequate pain relief in 70#x0025; to 90#x0025; of all cancer patients. Yet, despite these clear WHO guidelines, the pain problem has yet to be resolved. More recent studies on the prevalence of pain in patients with cancer are still high, ranging from 24#x0025; to 60#x0025; in patients on active anticancer treatment to 62#x0025; to 86#x0025; in patients with advanced cancer.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading